2^nd World Summit on Chemistry & Pharmaceutical Biotechnology

Dear Attendees,
 
We on behalf of our OCM's, Eminent Speakers and Times Scientific Group, warmly welcomes Professionals from Chemistry-Pharma-Biotech to have your valuable presence and Keynote Presentation at World CPB 2026, scheduled during July 13–14, 2026, in Berlin, Germany. 

Under single roof, we would like to gather Pharmaceutical Scientists, Biotechnologists, Pharmacologists, Medicinal Chemists, Drug Discovery, Researchers, Microbiologists, Bioinformaticians, Bioprocess Engineers, Academicians & University Professors and Lab Technologists across the world. Attendees will explore emerging therapeutic platforms, sustainable chemical processes, next-generation drug design, and advanced biomanufacturing strategies, all while addressing global challenges in healthcare, biotechnology, and responsible pharmaceutical development.

Progress in Chemistry & Biopharmaceutical Innovation
Rapid developments in molecular design, catalytic transformations, and green chemistry are reshaping modern drug discovery. Advances in synthetic biology, engineered enzymes, CRISPR-assisted production systems, and microreactor technologies are accelerating the creation of safer, more targeted therapeutics. Data-driven modelling, AI-guided compound optimization, and nanotechnology-based delivery systems are further expanding the horizons of pharmaceutical chemistry.

Breakthroughs in Pharmaceutical Biotechnology
Biotech-driven therapies are entering a new era with the evolution of cell-based medicines, mRNA platforms, advanced monoclonal antibodies, and precision biologics. Novel fermentation strategies, high-throughput screening, continuous manufacturing, and bio-analytics are enhancing product quality and reducing development timelines. The integration of digital tools, automation, and smart manufacturing is strengthening global biopharmaceutical reliability and efficiency. 

Europe’s Pivotal Role 
Europe remains a powerhouse in both chemical research and biotechnology, driving global standards through collaborative translational research, robust regulatory frameworks, and state-of-the-art pharmaceutical innovation. Academic–industry partnerships, strong investment in R&D, and a thriving ecosystem of biotech startups continue to propel breakthroughs across chemistry, drug formulation, and biologics manufacturing. 

Why Berlin, Germany? 
Berlin stands as one of Europe’s most dynamic centers for science and life-science innovation. The city hosts world-renowned universities, chemical research institutes, and biopharmaceutical hubs, making it an ideal destination for this summit. Beyond its academic excellence, Berlin offers exceptional connectivity, cultural diversity, and a stimulating environment for professional networking and scientific dialogue. 

Visa & Travel Support
Registered international delegates will receive official invitation letters to assist with visa processing. Early registration is highly recommended to ensure timely travel planning and seamless participation in all sessions, workshops, and networking events. 

Why to Attend? 
By joining the 2^nd World Summit on Chemistry & Pharmaceutical Biotechnology, you will: 
• Discover trends shaping the future of chemical science and pharmaceutical biotechnology. 
• Gain insights into innovative bioprocessing, molecular engineering, and therapeutic development.
• Engage with thought leaders, researchers, industrial experts, and regulatory professionals.
• Contribute to discussions driving global progress in sustainable chemistry and advanced biopharmaceutical technologies. 
We also invite exhibitors and sponsors from biotechnology, pharmaceutical manufacturing, chemical engineering, and analytical technologies to showcase their innovations to a distinguished audience of professionals and decision-makers.

Global Market Landscape (Chemistry & Pharmaceutical Biotechnology, 2024-2025)

United States: 
• Strong growth in biopharmaceutical production, driven by increased demand for biologics, mRNA therapies, and advanced chemical manufacturing technologies. 
• Investments in automation, continuous processing, and AI-driven drug development continue to expand the biotechnology and chemical sectors. 

Europe: 
•Steady expansion of the chemical and biopharmaceutical markets supported by advanced R&D infrastructure, regulatory leadership, and rapid adoption of sustainable chemical practices. 
• Rapidly increasing investment in pharmaceutical biotechnology, biomanufacturing facilities, and chemical process innovation. 
• Growth supported by government initiatives, expanded clinical research capacity, and heightened demand for cost-effective therapeutics.

So hereby, we will be highly obliged for you to join us in Berlin, Germany, to engage with global experts, showcase transformative research and explore the innovations shaping the future of chemistry and pharmaceutical biotechnology.

See you in Berlin, Germany!!!

Best regards,
Viviana Elise